SEARCH

SEARCH BY CITATION

References

  • 1
    Sutherland LR, May GR, Shaffer EA. Sulphasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993; 118: 5409.
  • 2
    Hanauer SB. Medical therapy of ulcerative colitis. Lancet 1993; 1: 4127.
  • 3
    Sutherland LR, Martin F, Greer S , et al. 5-aminosalicylic acid enemas in the treatment of distal ulcerative colitis, proctosigmoiditis and proctitis. Gastroenterology 1987; 92: 18948.
  • 4
    Marshall JK & Irvine EJ. Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis. Aliment Pharmacol Ther 1995; 9: 293300.
  • 5
    Sutherland LR & Martin F. 5-aminosalicylic acid enemas in the maintenance of remission in distal ulcerative colitis and proctitis. Am J Gastroenterol 1987; 1: 36.
  • 6
    Watkinson G. Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate. Br Med J 1958; 2: 107782.
  • 7
    Sutherland LR. Topical treatment of ulcerative colitis. Med Clin North Am 1990; 74: 11931.
  • 8
    Danish Budesonide Study Group. Budesonide in distal colitis. Scand J Gastroenterol 1991; 26: 12259.
  • 9
    Richter F & Scheppach W. Innovations in topical therapy. Baillieres Clin Gastroenterol 1997; 11: 97109.
  • 10
    Truelove SC. Treatment of ulcerative colitis with local hemisuccinate sodium. Br Med J 1958; 2: 10727.
  • 11
    Kornbluth A & Sachar DB. Ulcerative colitis practice guidelines in adults. Am J Gastroenterol 1997; 92: 20411.
  • 12
    Bowen GE, Irons GV, Rhodes JB, Kirsner JB. Early experiences with azathioprine in ulcerative colitis. J Am Med Assoc 1966; 195: 4604.
  • 13
    Bean RH. Treatment of ulcerative colitis with antimetabolites. Br Med J 1966; 1: 10814.
  • 14
    Jewell DP & Truelove SC. Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J 1974; 4: 62730.
  • 15
    Rosenberg JL, Wall AJ, Levin B, Binder HJ, Kirsner JB. A controlled trial of azathioprine in the management of chronic ulcerative colitis. Gastroenterology 1975; 69: 969.
  • 16
    Kirk AP & Lennard-Jones JE. Controlled trial of azathioprine in chronic ulcerative colitis. Br Med J 1982; 284: 12912.
  • 17
    Adler DJ & Korelitz BI. The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis. Am J Gastroenterol 1990; 85: 71722.
  • 18
    Hawthorne AB, Logan RFA, Hawkey CJ , et al. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. Br Med J 1992; 305: 202.
  • 19
    George J, Present DH, Pou R , et al. The long-term outcome of ulcerative colitis treated with 6-mercaptopurine. Am J Gastroenterol 1996; 91: 17114.
  • 20
    Lobo AJ, Foster PN, Burke DA, Johnston D, Axon ATR. The role of azathioprine in the management of ulcerative colitis. Dis Colon Rectum 1990; 33: 1825.
  • 21
    Lichtiger S & Present DH. Preliminary report: cyclosporine in the treatment of severe active ulcerative colitis. Lancet 1990; 336: 169.
  • 22
    Lichtiger S, Present DH, Kornbluth A , et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330: 18415.
  • 23
    Sandborn WJ. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. Am J Gastroenterol 1996; 91: 42343.
  • 24
    Steinhart AH, Brzezinski A, Baker JP. Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. Am J Gastroenterol 1994; 89: 17983.
  • 25
    Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI. 6-mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 1989; 111: 6419.
  • 26
    Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut 1993; 34: 10815.